Title: partial literature review on the threat of smallpox bioterrorism and response strategies
1partial literature review onthe threat of
smallpox bioterrorismand response strategies
- David Alderson
- January 2006
2references
- D.A. Henderson. The Looming Threat of
Bioterrorism. Science 2891279-1282, 1999. - C.J. Davis. Nuclear Blindness An Overview of
the Biological Weapons Programs of the Former
Soviet Union and Iraq. Emerging Infectious
Diseases 5509-512, 1999. - D.A. Henderson. Smallpox Clinical and
Epidemiologic Features. Emerging Infectious
Diseases 5537-539, 1999. - T. OToole. Smallpox An Attack Scenario.
Emerging Infectious Diseases 5540-546, 1999. - J. Bardi. Afterrmath of a Hypothetical Smallpox
Disaster. Emerging Infectious Diseases
5547-551, 1999. - M.I. Meltzer, I. Damon, J.W. LeDuc, and J.D.
Millar. Modeling Potential Responses to Smallpox
as a Bioterrorist Weapon. Emerging Infectious
Diseases 7(6) 959-969, Nov-Dec 2001. - T. OToole, M. Mair, T.V. Inglesby. Shining
Light on Dark Winter. Clinical Infectious
Diseases 34972-983, 2002. - E.H. Kaplan, D.L. Craft, and L.M. Wein.
Emergency Response to a Smallpox Attack The Case
for Mass Vaccination. Proc. Nat. Acad. Of Sci.
USA 99, 10935 (2002). - M.E. Halloran, I.M. Longini Jr., A. Nizam, and Y.
Yang. Containing Bioterrorist Smallpox. Science
298 1428-1432, 15 November 2002 - S.A. Bozzette, R. Boer, V. Bhatnagar, J.L. Brown,
E.B. Keeler, S.C. Morton, and M.A. Stoto. A
Model for a Smallpox-Vaccination Policy. The New
England Journal of Medicine 348(5) January 30,
2003. - E.H. Kaplan and L.M. Wein. Letter on Smallpox
Bioterror Response M.E. Halloran and I.M.
Longini Jr. Reponse to Letter. Science
3001503-1504, 6 June 2003. - 12. Edward H. Kaplan, David L. Craft, and
Lawrence M. Wein. Analyzing bioterror response
logistics the case of smallpox. Mathematical
Biosciences, Volume 185, Issue 1, September 2003,
Pages 33-72. - 13. Edward H. Kaplan. "Preventing second
generation infections in a smallpox bioterror
attack," Epidemiology, 15264-270, 2004.
3smallpox an abbreviated history
- 1949 last documented case of smallpox in US
- post-WWII large bioweapons effort by US, SU
- 1969 US unilaterally abandons program
- 1972 US halts systematic vaccination programs
- 1972 Biological and Toxin Weapons Convention
- SU signed, but didnt believe (or comply)
- 1970s SU estimated stockpile 20 tons
- 1990 SU capacity 80-100 tons smallpox/year
- 1978 last global case of smallpox
- 1974-1991 IRAQ operates bioweapons program
- 1991-?? covert IRAQ bioweapons program?
4smallpox todays threat
- US
- most susceptible population in modern times
- an unfamiliar disease
- Russian Federation
- unknown status of former programs
- location of bioweapons personnel?
- large stockpiles of weapons remain?
- security of smallpox virus?
- IRAQ
- extent of bioweapons program?
- location of bioweapons stockpiles?
5stages of smallpox infection
asymptomatic non-infectious vaccine sensitive
- vaccine only effective lt 3 days after initial
infection - vaccine complications 3/106 (death in 40 of
such cases)
3 days
incubating
asymptomatic non-infectious vaccine insensitive
- early detection isolation are most important
for treatment
10-14 days
- aches, fever, rash, pustular
- spread by inhalation
- 1g smallpox can infect 100 people via aerosol
symptomatic infectious vaccine insensitive
symptomatic
3-5 days
symptomatic isolated deceased / immune
- no cure
- mortality rate 30
removed
14-17 days
6smallpox policy questions
- detection an unfamiliar disease
- isolation who? when? how?
- vaccination who? when? how?
- how best to support a public health
infrastructure with limited resources? - coordination between federal and local govt
- managing information/media/mass hysteria
7vaccination strategies
- traced vaccination (TV) CDC plan c. 2002
- isolate symptomatic cases
- trace and vaccinate their contacts
- vaccinate more broadly if cant contain
- ring vaccination
- mass vaccination in region around outbreak
- limited vaccination
- pre-vaccinate health workers, first responders
- mass vaccination (MV)
- pre-vaccinate entire population
June 2001 US stockpile of smallpox vaccine
15.4 M doses
8simulated exercises
- First National Symposium on Medical and Public
Health Response to Bioterrorism - February 16-17, 1999, in Arlington, Virginia
- 950 public health officials, physicians, and
other medical personnel, along with government,
military, and intelligence experts - T. OToole. Smallpox An Attack Scenario.
Emerging Infectious Diseases 5540-546, 1999. - J. Bardi. Afterrmath of a Hypothetical Smallpox
Disaster. Emerging Infectious Diseases
5547-551, 1999. - Dark Winter
- June 22-23, 2001, Andrews Air Force Base
- Live simulation to examine challenges of
senior-level policy makers in response to a
hypothetical bioterrorist attack - T. OToole, M. Mair, T.V. Inglesby. Shining
Light on Dark Winter. Clinical Infectious
Diseases 34972-983, 2002.
9mathematical models
- typically, stochastic disease transmission
- primary uses
- to understand the potential magnitude of attack
scenarios - to evaluate the efficacy of prevention and
response strategies
10key parameters
- attack size of initial infection, location
- disease progression, transmission rate
- population size, type of mixing
- intervention start day, method
- vaccination resources stockpile, personnel
decision variables
- isolation who? when?
- vaccination who? when?
11Meltzer et al., EID 2001
- size of initial infection 100, 1000
- average transmission rate 3
- infinite population, homogeneous mixing
- unknown start of intervention 25, 30, 45 days
- unknown quarantine rate 25, 50 per day
- interventions quarantine, vaccination
- metric cumulative infections after 365 days
- metric length of time to halt virus
- conclusions either intervention can work alone
in theory but may take too long, should combine
them timely response is perhaps the most crucial
factor
12Kaplan, Craft, and Wein. PNAS 2002
- size of initial infection 1000
- average transmission rate 3
- population 10 million, homogeneous mixing
- 5000 vaccination personnel
- interventions TV, MV, CDC interim plan (TV?MV)
- tracing dynamics contact list size, fraction
named - policy-dependent vaccination rates
- metric time to implement, number of deaths
- conclusions logistics and limited TV resources
can constrain the efficacy of TV MV results in
fewer deaths than TV time to switch from TV to
MV is too costly so CDC should go with MV up front
13Halloran et al. Science 2002
- community population 2000, detailed structure
- structure-dependent transmission probabilities
- different levels of residual population immunity
- size of initial infection 1 or 5 unvaccinated
adults - interventions pre/post-attack MV, post-attack TV
- pre-attack MV at 30, 50, 80 levels
- post-attack MV 80 over 10 days
- post-attack TV 80, 100
- detailed spread through population
- metrics smallpox cases per 2000, doses per 2000
- conclusions timely MV can be better than TV but
not as dramatic as in Kaplan pre-existing herd
immunity helps both MV/TV and makes TV comparable
to MV
14Bozzette et al. NEJM 2003
- attack scenarios hoax, laboratory release, human
vectors, building attack, and low/high impact
airport - population size 500,000 4,000,000 (by
scenario) - size of initial infection 2-100,000 (by
scenario) - start of intervention 26 days
- control strategies contact vacc isolation
post-attack vacc of health care (HC) workers
post-attack vacc of HC public prior vacc of HC
post-attack vacc of public prior vacc of HC
public - conclusions highly scenario dependent
- no vacc best for hoax, lab, human vector
- prior vacc best for all only for high-impact
airport - prior vacc for HC best for low-impact airport,
building - thresholds lower for local governments
15preliminary conclusions
- relative efficacy of each vaccination strategy
depends on combinations of model-specific
parameters - choice of model features (e.g. vaccination
logistics) can sometimes dominate the result - highlighting the sensitivity of model inputs to
outcomes is perhaps most important feature - universal model agreement
- the response time is perhaps the most important
factor in containing an epidemic - there is a need for a larger vaccination
stockpile (NB after 9/11 US is stockpiling gt250M
doses)
The ability to respond rapidly at a national and
local level will depend on a state of readiness